Clinical Trial of CD19 Targeted CAR-T Cell in Refractory Adult SLE

Clinical trial NCT06892145 · RECRUITING

Trial details

NCT number: NCT06892145
Sponsor: Chongqing Precision Biotech Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus (SLE)Refractory

Start date: 2025-06-12
Primary completion: 2026-05-04
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.